Scientists create a new flu vaccine with nanoliposome technology
A new recombinant flu vaccine developed by a research team at the University at Buffalo has shown promising results in animal models, according to a study published in the journal Cell Reports Medicine. This vaccine, based on a nanoliposome platform called CoPoP, aims to address the shortcomings of traditional flu vaccines by inducing stronger and…